163 related articles for article (PubMed ID: 17621367)
41. HTLV-1 basic leucine zipper factor downregulates cyclin D1 expression via interactions with NF-κB.
Ma Y; Zhang B; Wang D; Qian L; Song X; Wang X; Yang C; Zhao G
Int J Mol Med; 2017 Mar; 39(3):764-770. PubMed ID: 28204810
[TBL] [Abstract][Full Text] [Related]
42. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.
Gazon H; Belrose G; Terol M; Meniane JC; Mesnard JM; Césaire R; Peloponese JM
Oncotarget; 2016 May; 7(21):30258-75. PubMed ID: 26849145
[TBL] [Abstract][Full Text] [Related]
43. The HBZ gene, a key player in HTLV-1 pathogenesis.
Matsuoka M; Green PL
Retrovirology; 2009 Aug; 6():71. PubMed ID: 19650892
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.
Arnold J; Yamamoto B; Li M; Phipps AJ; Younis I; Lairmore MD; Green PL
Blood; 2006 May; 107(10):3976-82. PubMed ID: 16424388
[TBL] [Abstract][Full Text] [Related]
45. The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies.
Hivin P; Basbous J; Raymond F; Henaff D; Arpin-André C; Robert-Hebmann V; Barbeau B; Mesnard JM
Retrovirology; 2007 Feb; 4():14. PubMed ID: 17306025
[TBL] [Abstract][Full Text] [Related]
46. [Mechanism of oncogenesis by human T-cell leukemia virus type 1].
Matsuoka M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):10-3. PubMed ID: 20087027
[TBL] [Abstract][Full Text] [Related]
47. HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes.
Suemori K; Fujiwara H; Ochi T; Ogawa T; Matsuoka M; Matsumoto T; Mesnard JM; Yasukawa M
J Gen Virol; 2009 Aug; 90(Pt 8):1806-1811. PubMed ID: 19423550
[TBL] [Abstract][Full Text] [Related]
48. The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.
Murata K; Yamada Y
Int Rev Immunol; 2007; 26(5-6):249-68. PubMed ID: 18027200
[TBL] [Abstract][Full Text] [Related]
49. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.
Younis I; Khair L; Dundr M; Lairmore MD; Franchini G; Green PL
J Virol; 2004 Oct; 78(20):11077-83. PubMed ID: 15452228
[TBL] [Abstract][Full Text] [Related]
50. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.
Matsumoto J; Ohshima T; Isono O; Shimotohno K
Oncogene; 2005 Feb; 24(6):1001-10. PubMed ID: 15592508
[TBL] [Abstract][Full Text] [Related]
51. [How and why HTLV-1 causes adult T-cell leukemia].
Matsuoka M
Rinsho Ketsueki; 2021; 62(7):744-750. PubMed ID: 34349058
[TBL] [Abstract][Full Text] [Related]
52. Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets.
Marino-Merlo F; Grelli S; Mastino A; Lai M; Ferrari P; Nicolini A; Pistello M; Macchi B
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834255
[TBL] [Abstract][Full Text] [Related]
53. Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo.
Miyazato P; Matsuoka M
Int Immunol; 2014 Aug; 26(8):419-25. PubMed ID: 24792037
[TBL] [Abstract][Full Text] [Related]
54. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
[TBL] [Abstract][Full Text] [Related]
55. HBZ, a new important player in the mystery of adult T-cell leukemia.
Mesnard JM; Barbeau B; Devaux C
Blood; 2006 Dec; 108(13):3979-82. PubMed ID: 16917009
[TBL] [Abstract][Full Text] [Related]
56. Enhanced Stabilization of MCL1 by the Human T-Cell Leukemia Virus Type 1 bZIP Factor Is Modulated by Blocking the Recruitment of Cullin 1 to the SCF Complex.
Mukai R; Ohshima T
Mol Cell Biol; 2016 Dec; 36(24):3075-3085. PubMed ID: 27697867
[TBL] [Abstract][Full Text] [Related]
57. Potential for molecular targeted therapy for adult T-cell leukemia/lymphoma.
Faris M
Int Rev Immunol; 2008; 27(1-2):71-8. PubMed ID: 18300056
[TBL] [Abstract][Full Text] [Related]
58. Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?
Barbeau B; Mesnard JM
Int Rev Immunol; 2007; 26(5-6):283-304. PubMed ID: 18027202
[TBL] [Abstract][Full Text] [Related]
59. Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor.
Matsuoka M; Yasunaga J
Curr Opin Virol; 2013 Dec; 3(6):684-91. PubMed ID: 24060211
[TBL] [Abstract][Full Text] [Related]
60. [Recent progress in ATL and HTLV-1 research].
Matsuoka M
Rinsho Ketsueki; 2008 Oct; 49(10):1508-14. PubMed ID: 18833935
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
